Introduction

Rede D’Or São Luiz (RDOR3) is one of the leading companies in Brazil’s private healthcare sector and one of the most relevant hospital groups listed on B3, Brazil’s stock exchange.

In this article, we analyze RDOR3 using fundamental indicators such as net income, P/E, P/B, EV/EBITDA, margins, ROE, ROA, ROIC, dividend yield, payout and debt.

The goal is to understand the company’s financial and operational quality and assess whether the stock appears cheap, reasonably priced or expensive based on its fundamentals.

Disclaimer: This article is for educational and informational purposes only. It is not a recommendation to buy, sell or hold any security. Fundamental indicators can change as the company’s results and share price change.

What is Rede D’Or?

Rede D’Or is one of Brazil’s largest private hospital networks. The company operates across several healthcare areas, including hospitals, diagnostic services, oncology and other medical services.

The company also has exposure to the private health insurance market through SulAmérica, giving it a broader presence across Brazil’s healthcare ecosystem.

Rede D’Or’s growth strategy has historically included organic expansion, acquisitions and increased healthcare capacity.

This strategy can generate economies of scale, but it also requires substantial investment in infrastructure, medical equipment, technology and human resources.

RDOR3: Growth and Profit Generation

One of the most important aspects of fundamental analysis is determining whether a company can transform revenue growth into earnings growth.

Rede D’Or has demonstrated significant historical growth. According to Investidor10 data, its five-year revenue CAGR is approximately 31.77%, while its net income CAGR is approximately 60.17%.

This is an important positive factor for the investment thesis because earnings have grown faster than revenue over the period analyzed.

However, investors should remember that historical growth does not guarantee the same growth rate in the future.

Net Income

Rede D’Or’s net income over the latest twelve-month period is approximately R$5 billion.

This represents a significant level of profitability for a company of its size.

Therefore, net income is one of the positive aspects of the fundamental analysis.

Assessment: GOOD.

Investors should nevertheless focus not only on the absolute amount of profit but also on its consistency and growth over time.

RDOR3 P/E Ratio

The P/E ratio compares the stock price with earnings per share.

In 2026, RDOR3’s P/E is in the region of 16–17 times, depending on the share price used.

This means investors are paying approximately 16 to 17 times the company’s annual earnings.

That is not an extremely low valuation. However, it is not necessarily excessive for a company with strong growth and profitability.

Assessment: REASONABLE.

The main risk is that investors pay a relatively high multiple while future earnings growth subsequently slows.

Price-to-Book Ratio

RDOR3’s price-to-book ratio is approximately 3.9 times.

In other words, the market values the company at several times its accounting equity.

A high P/B ratio can be justified when a company generates high returns on equity and has valuable operations and assets.

Nevertheless, based solely on this metric, the stock does not appear cheap.

Assessment: EXPENSIVE.

EV/EBITDA

EV/EBITDA is particularly useful when analyzing capital-intensive companies.

RDOR3 trades at approximately 6.8 times EBITDA.

This does not appear excessive considering the company’s scale and operating cash-generation capacity.

Assessment: GOOD/REASONABLE.

Gross Margin

Rede D’Or’s gross margin is approximately 23%.

This indicates the amount remaining from revenue after direct costs associated with delivering its services.

Compared with some sector benchmarks, gross margin is not one of the company’s strongest indicators.

Assessment: REASONABLE.

EBITDA Margin

The EBITDA margin is approximately 22%.

This is a positive indicator because it demonstrates substantial operating profitability relative to revenue.

The company’s EBITDA margin is also above the sector benchmark shown by Investidor10.

Assessment: GOOD.

Net Margin

Rede D’Or’s net margin is approximately 8%.

In simplified terms, this means that around R$8 of every R$100 in revenue becomes net income based on the period used in the calculation.

For a large company operating in the complex healthcare sector, this represents a meaningful level of profitability.

Assessment: GOOD.

ROE

ROE measures how efficiently a company generates profit from shareholders’ equity.

RDOR3’s ROE is approximately 23%.

This is one of the strongest points in the fundamental analysis.

A high ROE can indicate that management is using shareholders’ capital efficiently.

Assessment: VERY GOOD.

However, investors should always analyze ROE together with debt levels because financial leverage can affect the indicator.

ROA

ROA measures the return generated by a company’s assets.

RDOR3’s ROA is approximately 4.4%.

This may look relatively modest compared with companies in less capital-intensive industries. Hospitals, however, require significant investment in buildings, equipment and infrastructure.

Assessment: GOOD.

ROIC

ROIC measures the return generated on the capital invested in the company’s operations.

RDOR3’s ROIC is approximately 13% on the period considered.

This is another positive indicator and suggests that the company is generating meaningful returns on its operating capital.

Assessment: GOOD.

A recent Investidor10 report highlighted a ROIC of 32.6% in the first quarter of 2026, together with approximately R$2.9 billion in cash generation. Because different periods and methodologies can produce different ROIC figures, investors should avoid directly comparing the quarterly figure with a trailing-twelve-month calculation.

RDOR3 Dividends

Rede D’Or’s dividends deserve special attention.

In 2025, the company distributed approximately R$9.47 billion in dividends and interest on equity, compared with approximately R$4.84 billion in net income.

This resulted in a payout ratio of approximately 195.6%.

Therefore, the high recent dividend yield should be interpreted carefully.

A payout above 100% means distributions exceeded net income for that fiscal year. This can happen for several reasons, including distributions from reserves or extraordinary events, and does not necessarily mean that such a distribution level can be repeated indefinitely.

In 2026, the company had already approved R$750 million in interest on equity through payments approved in March and June.

Dividend yield assessment: VERY GOOD.

Payout sustainability assessment: CAUTION.

For a long-term investor, recurring cash generation and earnings are generally more important than simply looking at the dividend yield of a single period.

Rede D’Or Debt

Debt is another important issue.

RDOR3 has substantial gross debt in absolute terms, close to R$50.9 billion.

However, the company also has approximately R$43.3 billion in cash and equivalents, resulting in net debt of approximately R$7.6 billion.

This distinction is important.

A company can have substantial gross debt while maintaining a relatively comfortable financial position if it has sufficient cash and strong operating cash generation.

Net debt/EBITDA of approximately 0.6 times reinforces this view.

Assessment: GOOD.

Nevertheless, investors should monitor debt closely, particularly while interest rates remain elevated.

Macroeconomic Factors Affecting RDOR3

Interest Rates

High interest rates increase the cost of capital and make fixed-income investments more competitive compared with stocks.

A structural decline in Brazilian interest rates could potentially benefit risk assets and reduce financing costs.

Medical Inflation

Medical services, medicines, equipment and labor costs can put pressure on margins.

The company’s ability to pass higher costs through to customers and healthcare operators is therefore important.

Employment and Income

Growth in formal employment can support the expansion of employer-sponsored health insurance plans.

Employment, wages and economic activity are therefore relevant variables for healthcare companies.

Private Health Insurance

The number of Brazilians covered by private health insurance and the evolution of beneficiaries are important factors for the private hospital sector.

Regulation

Changes in regulations affecting private healthcare and the Brazilian health insurance market can affect hospitals, insurers and consumers.

Foreign Exchange

Medical equipment, medicines and certain inputs can have direct or indirect exposure to the U.S. dollar.

A significant depreciation of the Brazilian real can therefore increase certain costs.

Economic Growth

A stronger Brazilian economy can support employment, income and demand for private healthcare services.

Is RDOR3 Cheap or Expensive?

This is perhaps the most important question for investors.

A company can be excellent and still have an expensive stock price.

Using earnings per share and different P/E multiples, we can create a simplified valuation reference.

With earnings per share close to R$2.15, a P/E of 14 times would imply a reference value of approximately R$30 per share.

Using this framework, we can establish indicative price ranges:

Below R$30: potentially cheap/attractive.

R$30–R$35: attractive.

R$35–R$40: reasonable.

Above R$40: increasingly expensive, depending on future earnings growth.

These ranges are not official price targets. They are simply a simplified way of relating price to earnings.

If Rede D’Or continues growing earnings rapidly, a stock price that appears expensive today could become reasonable in the future.

Conversely, if earnings growth slows significantly, even a stock trading at a seemingly moderate P/E can experience valuation pressure.

Conclusion: Is RDOR3 a Good Company?

Rede D’Or’s fundamental analysis presents several positive characteristics.

The company has scale, strong growth, significant earnings, high ROE, positive ROIC, a meaningful EBITDA margin and relatively comfortable net debt compared with operating generation.

The main issue is valuation.

RDOR3 does not appear to be a classic “deep value” stock. The market recognizes the company’s quality and growth potential and therefore assigns a premium valuation to its equity.

Investors should also be careful when interpreting dividend yield because the 2025 payout was exceptionally high.

The conclusion can therefore be summarized as follows:

Company quality: GOOD.

Growth: VERY GOOD.

Profitability: GOOD/VERY GOOD.

Net debt: GOOD.

Dividends: ATTRACTIVE, but sustainability requires attention.

Valuation: REASONABLE, depending on the entry price.

For a long-term investor, the most important question is not simply:

“Is RDOR3 a good company?”

but rather:

“How much am I paying for a good company, and how much future growth is already reflected in the stock price?”

That distinction is fundamental to understanding the difference between analyzing a company and simply following its stock price.